Dynamic Expression of Membrane Type 1-Matrix Metalloproteinase (Mt1-mmp/Mmp14) in the Mouse Embryo.
Emma Muñoz-SáezNatalia MorachoAna I R LearteAlicia G ArroyoCristina Sánchez-CamachoPublished in: Cells (2021)
MT1-MMP/MMP14 belongs to a subgroup of the matrix metalloproteinases family that presents a transmembrane domain, with a cytosolic tail and the catalytic site exposed to the extracellular space. Deficient mice for this enzyme result in early postnatal death and display severe defects in skeletal, muscle and lung development. By using a transgenic line expressing the LacZ reporter under the control of the endogenous Mt1-mmp promoter, we reported a dynamic spatiotemporal expression pattern for Mt1-mmp from early embryonic to perinatal stages during cardiovascular development and brain formation. Thus, Mt1-mmp shows expression in the endocardium of the heart and the truncus arteriosus by E8.5, and is also strongly detected during vascular system development as well as in endothelial cells. In the brain, LacZ reporter expression was detected in the olfactory bulb, the rostral cerebral cortex and the caudal mesencephalic tectum. LacZ-positive cells were observed in neural progenitors of the spinal cord, neural crest cells and the intersomitic region. In the limb, Mt1-mmp expression was restricted to blood vessels, cartilage primordium and muscles. Detection of the enzyme was confirmed by Western blot and immunohistochemical analysis. We suggest novel functions for this metalloproteinase in angiogenesis, endocardial formation and vascularization during organogenesis. Moreover, Mt1-mmp expression revealed that the enzyme may contribute to heart, muscle and brain throughout development.
Keyphrases
- poor prognosis
- skeletal muscle
- cell migration
- endothelial cells
- spinal cord
- binding protein
- heart failure
- type diabetes
- gene expression
- crispr cas
- resting state
- randomized controlled trial
- dna methylation
- long non coding rna
- functional connectivity
- atrial fibrillation
- white matter
- cell proliferation
- subarachnoid hemorrhage
- cerebral ischemia
- metabolic syndrome
- transcription factor
- preterm infants
- quantum dots
- open label
- cerebral blood flow
- phase iii